Alnylam JPM 2025

Building a Top-Tier Biotech 43rd Annual J.P. Morgan Healthcare Conference Yvonne Greenstreet, MBChB Chief Executive Officer January 13, 2025 © 2025 Alnylam Pharmaceuticals, Inc. 1 Alnylam Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical statements of fact regarding Alnylam's expectations, beliefs, goals, plans or prospect ...